Adenocarcinoma News

Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma - Nature.com



Nature.com
 
Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma 
Nature.com
Pancreatic cancer: Intra-tumour bacteria promote gemcitabine resistance in pancreatic adenocarcinoma. Hugh Thomas. Bacteria within tumours could confer resistance to gemcitabine in patients with pancreatic adenocarcinoma (PDAC), reports a new study.

and more » 


Gastroesophageal adenocarcinoma patients benefit from adjuvant chemotherapy - Clinical Advisor



Clinical Advisor
 
Gastroesophageal adenocarcinoma patients benefit from adjuvant chemotherapy 
Clinical Advisor
(HealthDay News) ? Adjuvant chemotherapy is associated with improved survival for patients with locally-advanced gastroesophageal adenocarcinoma treated with preoperative chemoradiotherapy and resection, according to a study published online Sept.

and more » 


Utilization and Trends in Palliative Therapy for Stage IV Pancreatic Adenocarcinoma Patients: A US Population-based ... - Oncology Nurse Advisor



Oncology Nurse Advisor
 
Utilization and Trends in Palliative Therapy for Stage IV Pancreatic Adenocarcinoma Patients: A US Population-based ... 
Oncology Nurse Advisor
Background: Pancreatic adenocarcinoma is an aggressive malignancy, with most patients diagnosed with advanced or metastatic disease. Palliative therapies comprise an important, but underutilized, aspect of care. This aim of this study was to ...

 


RNA-Editing Protein ADAR Promotes Progression of Lung Cancer, New Study Finds - GenomeWeb



RNA-Editing Protein ADAR Promotes Progression of Lung Cancer, New Study Finds 
GenomeWeb
In order to examine the functional mechanisms of ADAR in lung adenocarcinoma cells, first author Elianna Amin and her colleagues knocked down ADAR abundance in lung adenocarcinoma cells, and found that reducing ADAR suppressed the cells' ...

and more » 


Endoscopic therapy effective in Barrett's carcinoma, dysplasia - Healio



Endoscopic therapy effective in Barrett's carcinoma, dysplasia 
Healio
?Barrett's esophagus with low-grade dysplasia often progresses to high-grade dysplasia, then intramucosal cancer and eventually on to invasive adenocarcinoma. This known progression provides opportunities to intervene before patients are diagnosed with ...

 


New target for treating ?undruggable? lung cancer - MIT News



MIT News
 
New target for treating ?undruggable? lung cancer 
MIT News
KEAP1 mutations occur alongside KRAS mutations in about 17 percent of lung adenocarcinoma cases. Tyler Jacks, director of MIT's Koch Institute for Integrative Cancer Research and co-senior author of the study, and his colleagues found that cancer cells ...
New system finds and targets vulnerabilities in lung cancer cells Medical Xpress

all 5 news articles » 


Esophageal cancer 'cell of origin' identified - Medical Xpress



Medical Xpress
 
Esophageal cancer 'cell of origin' identified 
Medical Xpress
Incidence of esophageal adenocarcinoma has risen by 800 percent over the past four decades. However, there has been little progress in screening and treatment over the same period. If esophageal cancer is not detected early, patients typically survive ...

and more » 


Types of cancer linked to weight - Motley Fool



Types of cancer linked to weight 
Motley Fool
Moving to the gastrointestinal tract and digestive system, esophageal adenocarcinoma, upper stomach cancer, gallbladder cancer, liver cancer, pancreatic cancer, and colorectal cancer all have been found to be associated with high weight levels. In ...

and more » 


Clinical factors predict response to therapy for pancreatic cancer - Healio



Clinical factors predict response to therapy for pancreatic cancer 
Healio
Researchers identified young age, low baseline cancer antigen 19-9 and use of gemcitabine as a radiosensitizer as clinical factors associated with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma ...

 


Pancreatic Ductal Adenocarcinoma Pipeline Insight, 2017 - E News Access (press release)



Pancreatic Ductal Adenocarcinoma Pipeline Insight, 2017 
E News Access (press release)
Pancreatic Ductal Adenocarcinoma- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the ...

and more »